Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro comes in six dosage levels — 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg — each supplied as a pre-filled KwikPen containing four weekly doses. The schedule is designed to be climbed gradually, letting your body adjust before the next step. These are prescription-only medicines; a GPhC-registered prescriber decides which strength is right for you and when to move up. Understanding how the levels work can help you have a more informed conversation with your clinical team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first pen's job is adjustment. At 2.5mg, the medicine is present at a level low enough to let your digestive system get used to the way tirzepatide slows gastric emptying and signals fullness through both GIP and GLP-1 receptors. Nausea and gut discomfort are most likely in the early weeks; starting low keeps those effects manageable for most people. The NHS medicines page for tirzepatide describes this starter phase clearly and is worth reading before your first pen arrives.
After four weeks, the prescriber reviews how you've tolerated things. If all is well, you move to 5mg. That pattern (four weeks at each level, then a clinical review before going further) continues up the ladder. Skipping steps is not something you can do yourself; it's a decision made with your prescriber based on your individual response, and for good reason. Pushing too fast typically means more side effects, not faster results.
One practical check worth building into your routine: before you start each new pen, you can read up on Mounjaro pens and dosage so you know exactly what strength to expect on the label and can catch any dispensing mix-up before the first injection. Small habit, real value.
As the dose increases, so does the clinical effect. The SURMOUNT-1 trial, published in the New England Journal of Medicine, found that participants taking tirzepatide 15mg lost an average of around 20–21% of body weight over 72 weeks, with some analyses putting that figure higher. Those results come from the higher mg levels, not from 2.5mg or 5mg alone. Reaching the maximum dose of Mounjaro is the goal for many people, though not everyone needs to get there to see meaningful results.
The intermediate levels (7.5mg, 10mg, and 12.5mg) are not simply waypoints to rush through. Some people find a dose that works well for them and stays there, particularly if they are losing weight steadily and tolerating the medicine well. The ceiling of 15mg is the highest licensed strength in the UK; going beyond it is not an option and is not something any legitimate prescriber would offer. If you're curious about the full Mounjaro dosing schedule and what governs each step, that page goes into more detail on how titration decisions are made.
Each strength is its own pre-filled KwikPen, colour-coded and clearly labelled. The pen contains four doses of a fixed strength, so once you start a 7.5mg pen, every injection from that pen is 7.5mg. When you move to the next level, you open a new pen at the higher strength. This matters practically: you cannot dial up a dose mid-pen the way you would with some insulin devices.
The volume delivered per injection does change across the Mounjaro dose levels in millilitres, and some people want to understand exactly what they're injecting. That information is covered in the product's SmPC on the eMC, which is the most reliable place to check precise delivery volumes for each pen. For the purposes of using the pen correctly, the label strength is the figure that matters day to day.
Injection sites (abdomen, thigh, or upper arm) should be rotated regardless of which dose level you're on. Storage requirements are the same across all strengths: refrigerated between 2°C and 8°C, with a limited room-temperature window set out in the Patient Information Leaflet. NICE's appraisal of tirzepatide (TA1026) covers the clinical evidence base that underpins the licensed dose range, and reading its summary gives useful context on why this particular ladder was chosen.
The short answer: they look at the whole picture, not just the number on the scale. Tolerability matters enormously. A prescriber who sees that you spent four weeks at 5mg feeling well and losing weight steadily will typically recommend moving up. One who hears about persistent nausea or significant gut disruption may suggest staying at the current level for another month before any increase. The prescriber's role is to find the highest dose that is effective for you without making daily life unpleasant.
At nume, every dose increase is reviewed clinically before a new pen is dispatched. That means providing evidence of your current weight and answering questions about how you've been tolerating things, a real prescriber reads your responses, not automated software. If you're considering treatment and want to understand more about the private route and what's assessed, starting a free consultation is the natural next step. Our clinical team, including our lead prescriber, reviews every case personally. There's also useful background on weight-loss treatment options more broadly if you're still weighing things up. Questions about cost sit separately, the Mounjaro pricing page explains what's included in a private prescription. And if the concept of a so-called "golden dose" has come up in your research, this page on whether the golden dose is safe covers what the evidence actually says.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.